Gangtok Chronicle

Pharmacogenomics Market Recent Trends, Future Growth, Industry Analysis, Forecasts Research, Top Manufacturers and Outlook 2027

 Breaking News
  • No posts were found

Pharmacogenomics Market Recent Trends, Future Growth, Industry Analysis, Forecasts Research, Top Manufacturers and Outlook 2027

April 06
22:45 2021
The study methodologies used to examine the Pharmacogenomics market for the forecast period, 2020 – 2027 further classifies the industry by type, geography, end-use and end-user to add more precision and bring to light factors responsible for augmenting business development.

The global Pharmacogenomics Market is expected to reach USD 11.97 Billion by 2027, according to a new report by Emergen Research. The global pharmacogenomics (PGx) market is growing at a substantial pace owing to the growing demand for personalized therapy, increasing prevalence of target chronic diseases, technological advancements, favorable government initiatives, availability of financial support for research and development.

Global Pharmacogenomics Market provides the latest information on the present and the future industry trends, allowing the readers to identify the products and services, hence driving the revenue growth and profitability. The research report provides an in-depth study of all the leading factors influencing the market on a global and regional level, including drivers, restraints, threats, challenges, opportunities, and industry-specific trends. Additionally, the report quotes worldwide certainties and countenance of along with downstream and upstream analysis of leading players.

 You Can Download Free Sample PDF Copy of Pharmacogenomics Market at https://www.emergenresearch.com/request-sample/88

Key Highlights From The Report

The software under the product and services segment is expected to have the largest market share. This is attributed to the widespread application of genomic data to effectively influence healthcare outcomes. The testing methods are improved, and the public and health care professionals are educated about the potential benefits owing to technological advancements.

The pharmacogenomics by application includes Oncology as one of the prospects which are expected to fuel the market growth. Pharmacogenomics is expected to help guide healthcare professionals to personalize treatment for cancer patients, which will contribute significantly to the market.

Research organizations held a significant share in 2019, owing to its contribution to the research field. It is a relatively new field that combines pharmacology and genomics to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.

The major driving factors for the growth of this market in the North American region is the rising demand for personalized medicines, high medical reimbursement facilities, and technological advancement.

Key participants include Abbott Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd, geneOmbio Technologies Pvt Ltd., Genomic Health, Inc., Illumina, Inc., and Laboratory Corporation of America Holdings, among others.

You Can Download Free Sample PDF Copy of Pharmacogenomics Market at https://www.emergenresearch.com/request-sample/88

Emergen Research has segmented the global Pharmacogenomicss market on the basis of interface, type, mode, end-users, and region:

Product and Services Outlook (Revenue, USD Billion; 2017-2027)

Products

Kits

Assays and Reagents

Instruments

Software

Services

Genotyping

SNP Identification

Pharmacogenetic Testing

Other Services

Technology Outlook (Revenue, USD Billion; 2017-2027)

Polymerase Chain Reaction (PCR)

Real-Time PCR

qPCR

Digital PCR

DNA Sequencing/Next Generation Sequencing (NGS)

Nucleic Acid Amplification Tests (NAATs)

Mass Spectrometry

Gel Electrophoresis

Hybridization

Fluorescence In Situ Hybridization (FISH)

Chromogenic In Situ Hybridization (CISH)

Others

Microarray

Others

Application Outlook (Revenue, USD Billion; 2017-2027)

Oncology

Infectious Diseases

Neurology/Psychiatry

Cardiovascular

Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)

Research Organization

Pharmaceutical Companies

Diagnostic Centers

Others

Regional scope – North America; Europe; Asia Pacific; Central & South America; MEA

Key questions answered in the report

What will be the market size in terms of value and volume in the next five years?

Which segment is currently leading the market?

In which region will the market find its highest growth?

Which players will take the lead in the market?

What are the key drivers and restraints of the market’s growth?

All of the segments studied in the research study are analyzed on the basis of BPS, market share, revenue, and other important factors. Our research study shows how different segments are contributing to the growth of the global Pharmacogenomics market. It also provides information on key trends related to the segments included in the report. This helps market players to concentrate on high-growth areas of the global Pharmacogenomics market. The research study also offers separate analysis on the segments on the basis of absolute dollar opportunity.

Read [email protected] https://www.emergenresearch.com/industry-report/pharmacogenomics-market

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Pharmacogenomics Market Segmentation & Impact Analysis

    4.1. Pharmacogenomics Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Growing adoption of medical marijuana for treatment of chronic diseases

                    4.2.2.2. Growing legalization of medical marijuana in various countries

          4.2.3. Market restraints analysis

                    4.2.3.1. Lower market access of marijuana due to absence of legalization programs

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Continued…

Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada
Website: https://www.emergenresearch.com/industry-report/pharmacogenomics-market


Warning: count(): Parameter must be an array or an object that implements Countable in /home/ghaziabadonline/gangtokchronicle.in/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share